Trade now with Barclays Stockbrokers
By Josh White
Date: Thursday 16 Jul 2026
(Sharecast News) - Oxford Biomedica announced on Thursday that it has signed an agreement to provide process development and AAV GMP manufacturing services to Plowshare Therapies, supporting the biotechnology company's gene therapy programme for rare genetic diseases.
| Holding(s) in Company | 14-Jul-2026 | 14:45 | RNS |
| Holding(s) in Company | 08-Jul-2026 | 17:57 | RNS |
| Total Voting Rights | 01-Jul-2026 | 07:00 | RNS |
| Admission to Trading | 22-Jun-2026 | 10:10 | RNS |
| Admission to trading application | 17-Jun-2026 | 08:10 | RNS |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
| Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 608.00p |
| Change Today | -38.00p |
| % Change | -5.88 % |
| 52 Week High | 913.00 |
| 52 Week Low | 370.00 |
| Volume | 379,227 |
| Shares Issued | 121.04m |
| Market Cap | £735.91m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:09 | 10,000 @ 608.00p |
| 16:35 | 93,177 @ 608.00p |
| 16:35 | 1,920 @ 608.00p |
| 16:35 | 1,781 @ 608.00p |
| 16:35 | 140 @ 608.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research